T1	Participants 700 725	patients with nodular BCC
T2	Participants 735 779	Twenty patients received three cycles of C&D
T3	Participants 1011 1104	Twenty patients were randomized to the imiquimod (n = 10) or vehicle (n = 10) treatment group
